首页 > 市场调查报告书 > 製药

妇科治疗

人绒毛膜促性腺激素 (HCG) 市场：按产品类型、治疗用途、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年

市场调查报告书

商品编码

1149866

人绒毛膜促性腺激素 (HCG) 市场：按产品类型、治疗用途、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年

Human Chorionic Gonadotropin Market, by Product Type, by Therapeutic Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年10月06日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3个工作天内

价格

简介目录

人绒毛膜促性腺激素 (HCG) 是受精卵着床后从胎盘分泌的一种激素。它也是一种支持卵子正常发育的激素，有助于促进卵子从卵巢中释放出来。 HCG 主要用于诱导接受生育治疗的女性排卵。它也用于男性，主要是为了增加精子数量，以及当年轻男性的睪丸由于垂体疾病或其他疾病而不能自然落入阴囊时。 HCG 通常作为皮下注射剂给予肌肉。 HCG 也可以在妇科医生或药剂师的建议下在家使用。 HCG 水平可以在尿液和血液检查的帮助下确定。某些测试的结果有助于确定准确的水平测量值。这些测试主要用于识别和确认怀孕或作为筛查测试以确定出生缺陷。这种激素刺激黄体产生黄体酮以维持妊娠。

市场动态

市场主要参与者越来越多地采用合作伙伴关係和收购等无机战略，预计将在预测期内推动市场增长。例如，2021 年 1 月，科技公司 Merck & Co., Inc. 宣布与健康科技公司 Royal Philips 建立多年合作伙伴关係，为高度个性化的生育治疗开发临床级数字解决方案。宣布将开发

这项研究的主要特点

本报告对全球人绒毛膜促性腺激素 (HCG) 市场进行了深入分析，包括以 2021 年为基准年的预测期（2022-2030 年）的市场规模（百万美元）和復合年增长率。（复合年增长率% ).
解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
它根据以下参数介绍了全球人绒毛膜促性腺激素 (HCG) 市场的主要参与者：公司亮点、产品组合、主要亮点、财务业绩和战略。
参与这项研究的主要公司包括 Merck & Co., Inc.、Ferring B.V.、Fresenius SE & Co.KGaA、Lupin、Sun Pharmaceutical Industries Ltd、Lee BioSolutions、Serum Institute of India Pvt. Ltd.、Scripps实验室、Sanzyme Biologics Pvt. Ltd.、VHB Medi Sciences Limited、Bharat Serums And Vaccines Limited (BSV)、Zydus Lifesciences Ltd、Corona Remedies Pvt.
这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
《全球人绒毛膜促性腺激素 (HCG) 市场报告》面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者将能够通过用于分析全球人绒毛膜促性腺激素 (HCG) 市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第二章市场展望

报告内容
- 市场定义和范围
执行摘要
- 按产品类型划分的市场概况
- 市场概况：按治疗用途分类
- 市场概况：按销售渠道
- 市场概况：按地区
连贯机会图 (COM)

第3章市场动态、规律及趋势分析

市场动态
- 司机
- 约束因素
- 商机
影响分析
商机
影响分析
市场趋势
主要亮点
HCG 剂型的变化
供应链分析
害虫分析
概览 - HCG 的主要治疗领域
主要品牌分析和定价分析
各国使用 HCG 治疗慢性疼痛的超说明书使用情况（2017 年至 2030 年）

第 4 章全球人绒毛膜促性腺激素 (HCG) 市场 - 冠状病毒 (COVID-19) 大流行的影响

对经济的影响
对供需的影响
COVID-19 的影响评估

第 5 章按产品类型分列的全球人绒毛膜促性腺激素 (HCG) 市场，2017-2030

人绒毛膜促性腺激素
人重组人绒毛膜促性腺激素
其他

第 6 章。全球人绒毛膜促性腺激素 (HCG) 市场：按治疗用途分类，2017-2030

男性性腺功能减退症
女性不孕症治疗
卵子发育不全治疗
慢性疼痛治疗
宫颈癌植物学处理
其他

第 7 章。全球人绒毛膜促性腺激素 (HCG) 市场：按分销渠道，2017-2030

医院药房
零售药房
在线药店

第 8 章全球人绒毛膜促性腺激素 (HCG) 市场：按地区划分，2017-2030

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
英国
德国
法国
意大利
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
东盟
其他亚太地区
中东
海湾合作委员会
以色列
其他中东地区
非洲
北非
中非
南非

第9章竞争格局

热图分析
市场份额分析
- Merck & Co., Inc.,
- Ferring B.V.
- Fresenius SE & Co.KGaA
- Lupin
- Sun Pharmaceutical Industries Ltd
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.,
- Scripps Laboratories
- Sanzyme Biologics Pvt.
- VHB Medi Sciences Limited
- Bharat Serums And Vaccines Limited
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.

第 10 章

调查方法介绍
关于出版商

简介目录

Product Code: CMI1011

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study:

This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Detailed Segmentation:

Global Human chorionic gonadotropin hormone (HCG) Market, By Product Type:
- Human Chorionic Gonadotropin
- Recombinant Human Chorionic Gonadotropin
Global Human chorionic gonadotropin hormone (HCG) Market,, By Therapeutic Application:
- Male Hypogonadism
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Chronic Pain
- Others
Global Human chorionic gonadotropin hormone (HCG) Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Human chorionic gonadotropin hormone (HCG) Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Merck & Co., Inc.,*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ferring B.V.,
- Fresenius SE & Co.KGaA
- Lupin
- Sun Pharmaceutical Industries Ltd
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.,
- Scripps Laboratories
- Sanzyme Biologics Pvt.
- VHB Medi Sciences Limited
- Bharat Serums And Vaccines Limited (BSV)
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutics Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Opportunities
Impact Analysis
Market Trends
Key Highlights
HCG Dosage Form Variation
Supply Chain Analysis
PEST Analysis
Overview- Major HCG Therapeutic Areas
Major Brand Analysis and Pricing Analysis
Off-label Usage of HCG for Chronic Pain (US$ Mn) By Country (2017-2030)

4. Global Human Chorionic Gonadotropin (HCG) Market- Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Human Recombinant Human Chorionic Gonadotropin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application , 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Male Hypogonadism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Female Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Oligospermic Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Cryptorchidism Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa